FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028082158> ?p ?o ?g. }

• W2028082158 abstract "Over the last decade, the treatment of heart failure has seen the introduction of several novel therapeutic avenues into the guidelines; however, these were mostly devoted to device therapies. Not much has changed with regards to the pharmacological treatment of this syndrome. Serelaxin, a recombinant form of the human peptide hormone relaxin-2, is a promising treatment candidate for patients presenting with acute heart failure. The Relaxin in Acute Heart Failure (RELAX-AHF) trial has shown beneficial effects in terms of relief of dyspnea and congestion in these patients. Even beneficial effects on short-term survival were reported. Another treatment approach to acute heart failure was pursued in the Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARRESS-HF) trial but the ultrafiltration used here lead to significantly worsened renal function as compared to standard pharmacologic care. Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy (MADIT-RIT) randomized patients with heart failure with a primary preventive indication for the implantation of an implantable cardioverter defibrillator to one of three algorithms for anti-tachycardia pacing (ATP) and shock. The authors found that initiation of such therapies only at higher heart rates than commonly used as threshold and longer time delays before the initiation of therapy may have two big advantages: the more conservative algorithms lead to a significant reduction in the cumulative probability of first inappropriate therapy and, even more striking, a reduced probability of death during follow-up. Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK-HF) showed beneficial outcomes for cardiac resynchronization therapy in heart failure patients with a mere pacemaker indication. Other studies discussed here embraced the course of body wasting, particularly cachexia, and muscle wasting in patients with heart failure and the influence of eating behavior." @default.
• W2028082158 created "2016-06-24" @default.
• W2028082158 creator A5042553930 @default.
• W2028082158 date "2013-05-09" @default.
• W2028082158 modified "2023-10-01" @default.
• W2028082158 title "Recent developments in the treatment of heart failure: highlights from the American Heart Association's Scientific Sessions, Los Angeles, California, 3 – 7 December 2012" @default.
• W2028082158 cites W1573768413 @default.
• W2028082158 cites W1965371986 @default.
• W2028082158 cites W1969716641 @default.
• W2028082158 cites W2003064100 @default.
• W2028082158 cites W2005933661 @default.
• W2028082158 cites W2019605946 @default.
• W2028082158 cites W2031905482 @default.
• W2028082158 cites W2079792861 @default.
• W2028082158 cites W2085548226 @default.
• W2028082158 cites W2104547465 @default.
• W2028082158 cites W2106569666 @default.
• W2028082158 cites W2108062940 @default.
• W2028082158 cites W2117743214 @default.
• W2028082158 cites W2119875370 @default.
• W2028082158 cites W2123336269 @default.
• W2028082158 cites W2131890284 @default.
• W2028082158 cites W2156552477 @default.
• W2028082158 cites W2160489474 @default.
• W2028082158 cites W2165742125 @default.
• W2028082158 cites W2321048056 @default.
• W2028082158 doi "https://doi.org/10.1517/13543784.2013.798301" @default.
• W2028082158 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23656525" @default.
• W2028082158 hasPublicationYear "2013" @default.
• W2028082158 type Work @default.
• W2028082158 sameAs 2028082158 @default.
• W2028082158 citedByCount "2" @default.
• W2028082158 countsByYear W20280821582014 @default.
• W2028082158 countsByYear W20280821582016 @default.
• W2028082158 crossrefType "journal-article" @default.
• W2028082158 hasAuthorship W2028082158A5042553930 @default.
• W2028082158 hasConcept C126322002 @default.
• W2028082158 hasConcept C164705383 @default.
• W2028082158 hasConcept C177713679 @default.
• W2028082158 hasConcept C2778198053 @default.
• W2028082158 hasConcept C71924100 @default.
• W2028082158 hasConceptScore W2028082158C126322002 @default.
• W2028082158 hasConceptScore W2028082158C164705383 @default.
• W2028082158 hasConceptScore W2028082158C177713679 @default.
• W2028082158 hasConceptScore W2028082158C2778198053 @default.
• W2028082158 hasConceptScore W2028082158C71924100 @default.
• W2028082158 hasLocation W20280821581 @default.
• W2028082158 hasLocation W20280821582 @default.
• W2028082158 hasOpenAccess W2028082158 @default.
• W2028082158 hasPrimaryLocation W20280821581 @default.
• W2028082158 hasRelatedWork W139393864 @default.
• W2028082158 hasRelatedWork W1544243753 @default.
• W2028082158 hasRelatedWork W1893228934 @default.
• W2028082158 hasRelatedWork W1976932138 @default.
• W2028082158 hasRelatedWork W2011535829 @default.
• W2028082158 hasRelatedWork W2023206272 @default.
• W2028082158 hasRelatedWork W2028567990 @default.
• W2028082158 hasRelatedWork W2069965924 @default.
• W2028082158 hasRelatedWork W2095329400 @default.
• W2028082158 hasRelatedWork W2329649037 @default.
• W2028082158 hasRelatedWork W2335630601 @default.
• W2028082158 hasRelatedWork W2360936483 @default.
• W2028082158 hasRelatedWork W2362580677 @default.
• W2028082158 hasRelatedWork W2429606870 @default.
• W2028082158 hasRelatedWork W2506073114 @default.
• W2028082158 hasRelatedWork W2748892655 @default.
• W2028082158 hasRelatedWork W2907959294 @default.
• W2028082158 hasRelatedWork W2996471467 @default.
• W2028082158 hasRelatedWork W605464984 @default.
• W2028082158 hasRelatedWork W1963844896 @default.
• W2028082158 isParatext "false" @default.
• W2028082158 isRetracted "false" @default.
• W2028082158 magId "2028082158" @default.
• W2028082158 workType "article" @default.